Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alan Mawson Insider Profile
4 Followers
Alan Mawson, Director at Fusion Antibodies Plc, holds 2.31M shares in Fusion Antibodies Plc (Ticker: GB:FAB). Most recently, Alan Mawson Sold 20,000p shares of Fusion Antibodies Plc on Sep 24, 2020 for an estimated value of 36.00K.
Profitable Transactions
8 out of 9 Profitable Transactions
Average Return
+96.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Alan Mawson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 17, 2020 - Mar 17, 2021
Return:+211.40%
The most profitable trade made by Alan Mawson
Alan Mawson's Trading History
List of latest transactions for each holding click on a transaction to see Alan Mawson's performance on stock
You May Also Like
Alan Mawson insider profile FAQ
What is the percentage of profitable transactions made by Alan Mawson?
The percentage of profitable transactions made by Alan Mawson is 89%.
What is the average return per transaction made by Alan Mawson?
The average return per transaction made by Alan Mawson is 96.00%.
What stocks does Alan Mawson hold?
Alan Mawson holds: GB:FAB stocks.
What was Alan Mawson’s latest transaction?
Alan Mawson latest transaction was an Informative Sell of 36.00K.
What was Alan Mawson's most profitable transaction?
Alan Mawson’s most profitable transaction was an Informative Buy of GB:FAB stock on March 17, 2020. The return on the trade was 211.40%.
What is Alan Mawson's role in Fusion Antibodies Plc?
Alan Mawson's role in Fusion Antibodies Plc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.